|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,473.20 INR | +0.46% |
|
+4.44% | -2.52% |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
Company Valuation: Cipla Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 821,377 | 726,839 | 1,208,588 | 1,164,745 | 988,887 | 1,190,125 | - | - |
| Change | - | -11.51% | 66.28% | -3.63% | -15.1% | 20.35% | - | - |
| Enterprise Value (EV) 1 | 810,334 | 716,397 | 1,154,239 | 1,084,736 | 901,599 | 1,084,051 | 1,058,681 | 1,042,289 |
| Change | - | -11.59% | 61.12% | -6.02% | -16.88% | 20.24% | -2.34% | -1.55% |
| P/E | 32.7x | 26x | 29.3x | 22.1x | 25.5x | 28.7x | 23.1x | 20.5x |
| PBR | 3.94x | 3.11x | 4.53x | 3.73x | 2.87x | 3.17x | 2.87x | 2.6x |
| PEG | - | 2.3x | 0.6x | 0.8x | -1x | 4.09x | 1x | 1.6x |
| Capitalization / Revenue | 3.77x | 3.19x | 4.69x | 4.23x | 3.51x | 3.84x | 3.43x | 3.14x |
| EV / Revenue | 3.72x | 3.15x | 4.48x | 3.94x | 3.2x | 3.5x | 3.05x | 2.75x |
| EV / EBITDA | 17.8x | 14.3x | 18.3x | 15.2x | 15.3x | 18.1x | 14.4x | 12.6x |
| EV / EBIT | 23.1x | 18.6x | 22x | 18x | 19.3x | 23.2x | 17.8x | 15.3x |
| EV / FCF | 29.1x | 29.9x | 38x | 28.2x | 38.5x | 38.2x | 28.7x | 25x |
| FCF Yield | 3.43% | 3.35% | 2.63% | 3.54% | 2.6% | 2.61% | 3.48% | 4% |
| Dividend per Share 2 | 5 | 8.5 | 13 | 13 | 13 | 12.76 | 14.4 | 14.28 |
| Rate of return | 0.49% | 0.94% | 0.87% | 0.9% | 1.06% | 0.87% | 0.98% | 0.97% |
| EPS 2 | 31.17 | 34.69 | 51.01 | 65.24 | 48 | 51.37 | 63.72 | 71.84 |
| Distribution rate | 16% | 24.5% | 25.5% | 19.9% | 27.1% | 24.8% | 22.6% | 19.9% |
| Net sales 1 | 217,633 | 227,531 | 257,741 | 275,476 | 281,626 | 309,889 | 347,298 | 379,577 |
| EBITDA 1 | 45,528 | 50,270 | 62,910 | 71,279 | 58,829 | 59,803 | 73,604 | 82,600 |
| EBIT 1 | 35,008 | 38,549 | 52,400 | 60,210 | 46,719 | 46,645 | 59,576 | 68,102 |
| Net income 1 | 25,168 | 28,019 | 41,216 | 52,725 | 38,792 | 41,350 | 51,420 | 57,963 |
| Net Debt 1 | -11,043 | -10,443 | -54,350 | -80,010 | -87,289 | -106,073 | -131,444 | -147,836 |
| Reference price 2 | 1,018.05 | 900.50 | 1,496.95 | 1,442.20 | 1,224.20 | 1,473.20 | 1,473.20 | 1,473.20 |
| Nbr of stocks (in thousands) | 806,814 | 807,151 | 807,367 | 807,617 | 807,783 | 807,850 | - | - |
| Announcement Date | 5/10/22 A | 5/12/23 A | 5/10/24 A | 5/13/25 A | 5/13/26 A | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.68x | 3.5x | 18.13x | 0.87% | 12.47B | |
| 36.37x | 6.89x | 23.79x | 0.86% | 50.03B | |
| 17.89x | 2.07x | 9.57x | 1.4% | 36.6B | |
| 26.71x | 3.94x | 16.04x | 0.59% | 11.77B | |
| 19x | 3.32x | 11.92x | 3.5% | 9.04B | |
| 15.69x | 2.02x | 6.33x | 3.29% | 7.03B | |
| 8.24x | 1.93x | 5.06x | 5.26% | 6.79B | |
| 33.91x | 3.86x | 16.43x | 0.24% | 6.6B | |
| 41.33x | 7.92x | 29.37x | 0.96% | 4.53B | |
| Average | 25.31x | 3.94x | 15.18x | 1.88% | 16.1B | |
| Weighted average by Cap. | 26.89x | 4.34x | 16.45x | 1.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CIPLA Stock
- Valuation Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
